| Urinary and renal interstitial concentrations of TNF-α increase prior to the rise in albuminuria in diabetic rats K Kalantarinia, AS Awad, HM Siragy Kidney international 64 (4), 1208-1213, 2003 | 217 | 2003 |
| Ultrasound prevents renal ischemia-reperfusion injury by stimulating the splenic cholinergic anti-inflammatory pathway JC Gigliotti, L Huang, H Ye, A Bajwa, K Chattrabhuti, S Lee, AL Klibanov, ... Journal of the American Society of Nephrology 24 (9), 1451-1460, 2013 | 199 | 2013 |
| Assessment of intravascular volume status and volume responsiveness in critically ill patients K Kalantari, JN Chang, C Ronco, MH Rosner Kidney international 83 (6), 1017-1028, 2013 | 163 | 2013 |
| Real-time measurement of renal blood flow in healthy subjects using contrast-enhanced ultrasound K Kalantarinia, JT Belcik, JT Patrie, K Wei American Journal of Physiology-Renal Physiology 297 (4), F1129-F1134, 2009 | 111 | 2009 |
| Ultrasound modulates the splenic neuroimmune axis in attenuating AKI JC Gigliotti, L Huang, A Bajwa, H Ye, EH Mace, JA Hossack, K Kalantari, ... Journal of the American Society of Nephrology 26 (10), 2470-2481, 2015 | 103 | 2015 |
| Novel imaging techniques in acute kidney injury K Kalantarinia Current drug targets 10 (12), 1184-1189, 2009 | 77 | 2009 |
| Validation of the pulse decomposition analysis algorithm using central arterial blood pressure MC Baruch, K Kalantari, DW Gerdt, CM Adkins Biomedical engineering online 13, 1-19, 2014 | 67 | 2014 |
| Ultrasound contrast agents in the study of kidney function in health and disease K Kalantarinia, MD Okusa Drug Discovery Today: Disease Mechanisms 4 (3), 153-158, 2007 | 57 | 2007 |
| A good reason to measure 24-hour urine creatinine excretion, but not to assess kidney function K Kalantari, WK Bolton Clinical Journal of the American Society of Nephrology 8 (11), 1847-1849, 2013 | 41 | 2013 |
| The choice of vascular access for therapeutic apheresis K Kalantari Journal of clinical apheresis 27 (3), 153-159, 2012 | 41 | 2012 |
| Higher doses of erythropoietin-stimulating agents and hyporesponsiveness to their effects are associated with increased mortality among prevalent hemodialysis patients A Nishio, BP Chhatkuli, JZ Ma, K Kalantari Blood purification 36 (1), 29-36, 2013 | 31 | 2013 |
| Vascular access considerations for therapeutic apheresis procedures C Okafor, K Kalantarinia Seminars in dialysis 25 (2), 140-144, 2012 | 24 | 2012 |
| Isolated polyarticular septic arthritis: an atypical presentation of meningococcal infection M Mcculloch, H Brooks, K Kalantarinia The American journal of the medical sciences 335 (4), 323-326, 2008 | 21 | 2008 |
| Novel therapeutic approaches to lupus glomerulonephritis: translating animal models to clinical practice H Bagavant, K Kalantarinia, Y Scindia, U Deshmukh American journal of kidney diseases 57 (3), 498-507, 2011 | 20 | 2011 |
| The renin-angiotensin system and its blockade in diabetic renal and cardiovascular disease K Kalantarinia, MD Okusa Current Diabetes Reports 6 (1), 8-16, 2006 | 20 | 2006 |
| Renal collectrin protects against salt-sensitive hypertension and is downregulated by angiotensin II PL Chu, JC Gigliotti, S Cechova, G Bodonyi-Kovacs, F Chan, DL Ralph, ... Journal of the American Society of Nephrology 28 (6), 1826-1837, 2017 | 18 | 2017 |
| The role of imaging in the management of cardiorenal syndrome SM George, K Kalantarinia International journal of nephrology 2011 (1), 245241, 2011 | 17 | 2011 |
| The use of iodinated contrast media in patients with end-stage renal disease. SF Khan, K Kalantari Seminars in Dialysis 27 (6), 2014 | 10 | 2014 |
| Endocrinology and Dialysis: Management of Lipid Abnormalities Associated with End‐Stage Renal Disease J Liu, K Kalantarinia, MH Rosner Seminars in Dialysis 19 (5), 391-401, 2006 | 10 | 2006 |
| Recent advances in the pharmacological management of sepsis-associated acute kidney injury K Kalantari, MH Rosner Expert Review of Clinical Pharmacology 14 (11), 1401-1411, 2021 | 9 | 2021 |
